Navigation Links
Experts Critical of a New OTC Product to Treat Psoriasis

Psoriasis is marked by scaly, itchy, occasionally painful rashes. Prescription medications including steroid creams that ease inflammation are far from perfect.

When over five million Americans suffer from that skin condition, any claims of permanent cure, can evoke frenzied response, especially when backed by some kind of evidence. And that is what is happening to Skin Zinc, even though experts are skeptical.

"We can control psoriasis, but we can't cure it," says Dr. Steven Feldman, professor of dermatology at Wake Forest University. "People want something magical that will work without side effects."

The SkinZinc system sold at major drugstores and over the Internet combines two products: SkinZinc spray and SkinCylic cream. The active ingredient in the spray is a 0.25% solution of zinc pyrithione, the same active ingredient found in Head & Shoulders dandruff shampoo SkinCylic the cream contains 2% salicylic acid, a common ingredient in both prescription and over-the-counter psoriasis treatments. The Walgreen's website sells 4 ounces each of the spray and the cream for about $40.

"Patients ask about SkinZinc very frequently," says Dr. Kenneth Gordon, assistant professor of dermatology at Northwestern University and a medical board member of the National Psoriasis Foundation. "I know I have many patients who have gone out and bought it."

Bernard Willimann, executive vice president for Preval Health, the Maine-based company behind SkinZinc, says that the system is the bestselling over-the-counter treatment for psoriasis in the U.S. and Canada. "Some people try it without success, but a lot of people are very loyal to it," he says. "Some of the letters and pictures we get are amazing."

In one radio spot, an unidentified customer calls it "the closest thing to a medical miracle." Ads in national magazines claim that the SkinZinc spray "goes on like water to help eliminate painful, stubborn
'"/>




Page: 1 2 3

Related medicine news :

1. Good carb, bad carb? Experts debate.
2. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
3. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
4. Experts Insist That Neonatal Herpes Be Reported Regularly
5. Experts State Strategies To Increase Good Cholesterol
6. Cancer Can Recur Any Time, Experts Caution
7. Experts Building Bird Flu Warning System
8. Human Growth Hormone (HGH) - View of Experts
9. Experts urging artery screening in the UK
10. Genetic Experts of Hopkins Assists In Identifying Hurricane Katrina Victims
11. Birds Being Shot Owing To Bird Flu Fear: Wildlife Experts
Post Your Comments:
Other Medicine News:Health News:UnitedLex Announces Strategic Alliance with Oval Ideas to Enable Superior Patent Analytics 2Health News:What's That Smell? Ask a Woman, Not a Man 2Health News:Acid Erosion In Children's Teeth Growing Concern Among Dentists 2Health News:Acid Erosion In Children's Teeth Growing Concern Among Dentists 3Health News:Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States 2Health News:Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States 3Health News:Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States 4Health News:Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States 5Health News:Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States 6Health News:Introducing solixir(TM)... The First All-Natural Sparkling Botanical Beverage to Hydrate Body and Soul 2Health News:Introducing solixir(TM)... The First All-Natural Sparkling Botanical Beverage to Hydrate Body and Soul 3
Breaking Medicine Technology:Pharmacy Technician Employment Increasing Up to 32% By 2016 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 1Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 2Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 3Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 4Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 5Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 6Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study 5663 1Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study 5663 2NASCAR Camping World Truck Series Driver Aric Almirola Waves the Yellow Flag at Warning Signs of Skin Cancer 5659 1NASCAR Camping World Truck Series Driver Aric Almirola Waves the Yellow Flag at Warning Signs of Skin Cancer 5659 2NASCAR Camping World Truck Series Driver Aric Almirola Waves the Yellow Flag at Warning Signs of Skin Cancer 5659 3
Other Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8